男男情头一攻一受

 
Disclosure of Shareholdings

Disclosure of Shareholdings

Anyone who directly or indirectly or acting in concert with third parties acquires or disposes of shares in Vifor Pharma or enters into acquisition or sale rights relating to shares in Vifor Pharma and thereby reaches, falls below or exceeds the thresholds of 3%, 5%, 10%, 15%, 20%, 25%, 33⅓%, 50% or 66⅔% of the voting rights, whether exercisable or not must notify this to Vifor Pharma and the SIX Swiss Exchange. The detailed disclosure requirements and the methodology for calculating the thresholds are set out in the relevant Swiss regulations.

Information on disclosures of significant shareholdings can be found on the following website of the SIX Swiss Exchange: /en/home/publications/significant-shareholders.html.

Shareholders are advised to consult their own legal counsel to make themselves familiar with their notification requirements and to address their particular situation and their specific questions.

Contact

Shareholder Services
Vifor Pharma Ltd.

Email: shareholders@viforpharma.com